Cargando…
Combined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy
PURPOSE: We investigated the visual outcome of combined phacoemulsification with intravitreal bevacizumab, in eyes with dense cataract and visually significant exudative maculopathy. MATERIALS AND METHODS: Prospective longitudinal pilot study of consecutive patients treated by two surgeons in 2006,...
Autores principales: | Mansour, Ahmad, Bashshur, Ziad F., Sibai, Tarek A., Mehio-Sibai, Abla, Hamam, Rola N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110440/ https://www.ncbi.nlm.nih.gov/pubmed/21713234 http://dx.doi.org/10.4103/0974-620X.77656 |
Ejemplares similares
-
Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization
por: Mansour, Ahmad M, et al.
Publicado: (2012) -
Exploring resident-staff relationships in nursing homes in Lebanon
por: Gharibian Adra, Marina, et al.
Publicado: (2019) -
Paraneoplastic acute exudative polymorphous vitelliform maculopathy improved with intravitreal methotrexate
por: Gao, Jie, et al.
Publicado: (2020) -
Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab
por: Kaplan, Richard I, et al.
Publicado: (2017) -
Mapping genetic research in non-communicable disease publications in selected Arab countries: first step towards a guided research agenda
por: Jamaluddine, Zeina, et al.
Publicado: (2016)